Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

CED-9 Inhibitors

CED-9 Inhibitors belong to a class of chemical compounds designed to target and inhibit the function of the CED-9 protein, which plays a pivotal role in apoptosis regulation within the nematode Caenorhabditis elegans. Apoptosis, or programmed cell death, is a fundamental process in multicellular organisms, ensuring the removal of unwanted or damaged cells. In C. elegans, CED-9 functions as an anti-apoptotic protein, preventing cell death by inhibiting the activation of pro-apoptotic factors. CED-9 inhibitors are developed to interfere with the protective function of CED-9, allowing the study of apoptosis and cell death in this model organism. The development of CED-9 inhibitors is closely tied to research in molecular biology, genetics, and cell biology, as they are primarily used as experimental tools to elucidate the mechanisms of apoptosis regulation. Researchers often utilize C. elegans as a model organism due to its well-characterized genetic and molecular pathways. To develop CED-9 inhibitors, scientists identify small molecules or compounds that can interfere with the binding of CED-9 to its pro-apoptotic targets, such as CED-4. These inhibitors can be natural compounds, synthetic chemicals, or genetic mutations in C. elegans. By inhibiting CED-9, researchers can induce apoptosis in specific cells, allowing the study of apoptotic pathways, cell fate determination, and the role of individual genes in the process.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Chelerythrine chloride

3895-92-9sc-3547
sc-3547A
5 mg
25 mg
$90.00
$317.00
17
(1)

Chelerythrine is a benzophenanthridine alkaloid that can act as a protein kinase C inhibitor, which might affect signal transduction pathways and could indirectly influence the expression of apoptotic regulators homologous to CED-9.

Sanguinarium

2447-54-3sc-473396
10 mg
$220.00
(0)

Sanguinarium, another benzophenanthridine alkaloid, could inhibit NF-κB activation, which may be involved in the transcriptional regulation of apoptosis-related genes and thereby might affect CED-9 expression.

Obatoclax

803712-67-6sc-507476
10 mg
$348.00
(0)

Obatoclax is a small-molecule pan-Bcl-2 antagonist that could theoretically inhibit proteins similar to CED-9 by binding to the hydrophobic groove on Bcl-2 family proteins, potentially influencing their expression.

ABT 737

852808-04-9sc-207242
2.5 mg
$204.00
54
(3)

ABT 737 is a Bcl-2 family protein antagonist that could mimic the inhibition of Bcl-2-like proteins and might affect the expression of CED-9 homologs by modulating the intrinsic apoptotic pathway.

Gossypol

303-45-7sc-200501
sc-200501A
25 mg
100 mg
$116.00
$230.00
12
(1)

Gossypol is a natural compound that acts as a Bcl-2 inhibitor, which could influence pathways similar to those regulated by CED-9 in C. elegans by binding to the BH3 domain on Bcl-2 family proteins.

TW-37

877877-35-5sc-361387
sc-361387A
10 mg
50 mg
$200.00
$860.00
2
(1)

TW-37 is designed to bind to the BH3 binding groove of Bcl-2 proteins, potentially influencing similar regulatory proteins in C. elegans and could hypothetically affect CED-9 expression.

Piperlongumine

20069-09-4sc-364128
10 mg
$107.00
(1)

Piperlongumine increases the levels of reactive oxygen species, which can affect signaling pathways and potentially reduce the expression of apoptosis-regulating proteins such as CED-9.

Phenethyl isothiocyanate

2257-09-2sc-205801
sc-205801A
5 g
10 g
$104.00
$183.00
2
(1)

This compound modifies proteins through alkylation and can disrupt multiple cellular processes, potentially including those regulating the expression of proteins like CED-9.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$111.00
$357.00
8
(0)

Thalidomide affects various signaling pathways and has been shown to downregulate Bcl-2 family proteins, which suggests it could have a similar effect on CED-9 expression.